Market Narratives

Tesla and Rivian have rallied solidly in recent months as investors front-run the upcoming delivery report, but NIO and Li Auto have not yet participated, leaving a meaningful catch-up gap. While both laggards are heavyweights requiring significant capital to move, a strong delivery print could spark a spillover trade into these underperformers. The wide gap between leaders and laggards sets up a potential rotation if sentiment broadens.

Leaders have already surged on the nuclear-for-AI narrative, but laggards with nuclear exposure are still pricing in the opportunity. The wide performance gap between front-runners and these slower movers sets up a compelling catch-up trade as the theme broadens beyond the early beneficiaries.

Pharmaceutical giants are in the midst of a record-breaking M&A wave, with leading names like LLY and NVO already surging on the trend. Heavyweight laggards—MRK, BMY, and PFE—remain well behind, presenting a meaningful catch-up opportunity, though their massive market caps demand significant capital to move. The flat or falling performance of these laggards underscores the market's anticipation of their need to acquire or be acquired.